Update: April 6, 2026 (12:26 AM ET): In an emailed clarification to Android Authority, Samsung said that the BP monitoring feature on Galaxy Watches in the US is not intended for medical use and therefore doesn’t require FDA clearance. Here’s Samsung’s full answer to our question about FDA approvals for the feature:
Samsung’s Blood Pressure Monitoring feature is designed as a wellness feature and is not intended for medical use. As such, it is not subject to FDA clearance. The feature aligns with the FDA’s General Wellness: Policy for Low-Risk Devices , including updates published in January 2026 focused on consumer wearables.
Original article: March 31, 2026 (9 AM ET): Samsung is finally introducing blood pressure monitoring on Galaxy Watches in the US. The feature will be available on Galaxy Watch 4 and later models running Watch OS 4.0 or later.